These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36942294)

  • 41. Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials.
    Nader A; Stodtmann S; Friedel A; Mohamed MF; Othman AA
    J Clin Pharmacol; 2020 Apr; 60(4):528-539. PubMed ID: 31701537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4.
    Ichise Y; Saegusa J; Tanaka-Natsui S; Naka I; Hayashi S; Kuroda R; Morinobu A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32674360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacological profile of anti-human TNF alpha monoclonal antibody, infliximab (Remicade)].
    Sugita T
    Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):57-64. PubMed ID: 12617039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mathematical modelling of cytokine-mediated inflammation in rheumatoid arthritis.
    Baker M; Denman-Johnson S; Brook BS; Gaywood I; Owen MR
    Math Med Biol; 2013 Dec; 30(4):311-37. PubMed ID: 23002057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Targeting therapy for inflammatory diseases by anti-TNFalpha biologics].
    Sugita T
    Yakugaku Zasshi; 2009 Jan; 129(1):19-24. PubMed ID: 19122432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Taming TNF: strategies to restrain this proinflammatory cytokine.
    Eigler A; Sinha B; Hartmann G; Endres S
    Immunol Today; 1997 Oct; 18(10):487-92. PubMed ID: 9357141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis.
    Shi XZ; Winston JH; Sarna SK
    Am J Physiol Gastrointest Liver Physiol; 2011 Jan; 300(1):G41-51. PubMed ID: 20947704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rheumatoid arthritis and cytokines].
    Kaneko S; Kondo Y; Yokosawa M; Sumida T
    Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-inflammatory effects of ursolic acid-3-acetate on human synovial fibroblasts and a murine model of rheumatoid arthritis.
    Lee JY; Choi JK; Jeong NH; Yoo J; Ha YS; Lee B; Choi H; Park PH; Shin TY; Kwon TK; Lee SR; Lee S; Lee SW; Rho MC; Kim SH
    Int Immunopharmacol; 2017 Aug; 49():118-125. PubMed ID: 28577436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effect of Corynoline on the CFA induced Rheumatoid arthritis via attenuation of oxidative and inflammatory mediators.
    Weng W; Wang F; He X; Zhou K; Wu X; Wu X
    Mol Cell Biochem; 2021 Feb; 476(2):831-839. PubMed ID: 33174074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts.
    Lowin T; Tingting R; Zurmahr J; Classen T; Schneider M; Pongratz G
    Cell Death Dis; 2020 Sep; 11(8):714. PubMed ID: 32873774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug disease interactions: role of inflammatory mediators in disease and variability in drug response.
    Kulmatycki KM; Jamali F
    J Pharm Pharm Sci; 2005 Dec; 8(3):602-25. PubMed ID: 16401407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-6 in rheumatoid arthritis.
    Nishimoto N
    Curr Opin Rheumatol; 2006 May; 18(3):277-81. PubMed ID: 16582692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective acute inflammation in Crohn's disease: a clinical investigation.
    Marks DJ; Harbord MW; MacAllister R; Rahman FZ; Young J; Al-Lazikani B; Lees W; Novelli M; Bloom S; Segal AW
    Lancet; 2006 Feb; 367(9511):668-78. PubMed ID: 16503465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokine inhibitors in the treatment of rheumatoid arthritis.
    Gabay C
    Expert Opin Biol Ther; 2002 Feb; 2(2):135-49. PubMed ID: 11849114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis.
    Riegsecker S; Wiczynski D; Kaplan MJ; Ahmed S
    Life Sci; 2013 Sep; 93(8):307-12. PubMed ID: 23871988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.